March 27, 2024

Swine Vaccines Market Size to Rake US$ 6.5 billion by 2030

According to Report, the Swine Vaccines Market size is expected to reach around US$ 6.5 billion by 2030 and is anticipated to grow at a CAGR of 5.9% during forecast period 2021 to 2030.

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39081

Increasing prevalence of diseases, a surge in the demand for animal protein, and growth in R&D expenditure for vaccines innovation are driving the market growth. Porcine Parvovirus (PPV), Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine circovirus type 2 (PCV2), Foot & Mouth Disease, Classical Swine Fever, and others remain to be extremely prevalent diseases in pig farms affecting economic losses.

Swine production is a key component of global food security, agricultural countries, and local & international business. Contagious diseases impact pig health and stability and productivity of the swine industry globally. Thus, the rising prevalence of diseases in swine is estimated to drive the market over the forecast years. Porcine Parvovirus (PPV) is a reproductive disease present in most pig farms globally. Porcine Reproductive and Respiratory Syndrome (PRRS) remains to be a highly prevalent disease in pig farms affecting economic losses through its adverse effects on reproduction and growth as well as by clinical illness.

Report Coverage

Report ScopeDetails
Market SizeUS$ 6.5 billion by 2030
Growth RateCAGR of 5.9% From 2021 to 2030
Largest MarketAsia Pacific
Base Year2021
Forecast Period2021 to 2030
Segments CoveredProduct, Type
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies MentionedMerck Animal Health; Ceva; Zoetis; BoehringerIngelheim GmbH; Elanco; Indian Immunologicals Ltd.; BiogénesisBagó; Phibro Animal Health; KM Biologics; HIPRA

COVID-19 has compressed the global economy and with it the manufacturing and marketing sector, production, disruption, financial.

The significant drop in COVID-19 cases due to mass inoculations programs worldwide are anticipated to increase revenue flow in the global economy and contribute to the growth of the car electrical products market. The COVID-19 impact has changed the growth projections of many sectors and businesses. The analysts put their excellent and well-researched opinions in the report. The opinions will help the stakeholders to make their strategy accordingly.

Key Players

  • Merck Animal Health
  • Ceva
  • Zoetis
  • Boehringer Ingelheim GmbH
  • Elanco
  • Indian Immunologicals Ltd.
  • BiogénesisBagó
  • Phibro Animal Health
  • KM Biologics
  • HIPRA

Market Segmentation

  • By Type
    • Swine Influenza
    • Classical Swine Fever
    • Porcine Parvovirus
    • Porcine Circovirus Type 2
    • M.Hyo
    • ActinobacillusPleuropneumonia
    • PRRS
    • Foot & Mouth Disease
    • Pseudorabies
    • PEDV
    • Others
  • By Product
    • Attenuated Live Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • Regional
    • North America
      • U.S.
      • Canada
    •  Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East and Africa (MEA)
      • Saudi Arabia
      • South Africa

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39081

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Swine Vaccines Market, By Type

7.1.  Swine Vaccines Market, by Type, 2021-2030

7.1.1.    Swine Influenza

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Classical Swine Fever

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Porcine Parvovirus

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Porcine Circovirus Type 2

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    M.Hyo

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    ActinobacillusPleuropneumonia

7.1.6.1.        Market Revenue and Forecast (2017-2030)

7.1.7.    PRRS

7.1.7.1.        Market Revenue and Forecast (2017-2030)

7.1.8.    Foot & Mouth Disease

7.1.8.1.        Market Revenue and Forecast (2017-2030)

7.1.9.    Pseudorabies

7.1.9.1.        Market Revenue and Forecast (2017-2030)

7.1.10.  PEDV

7.1.10.1.      Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Swine Vaccines Market, By Product

8.1.  Swine Vaccines Market, by Product, 2021-2030

8.1.1.    Attenuated Live Vaccines

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Inactivated Vaccines

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Subunit Vaccines

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    DNA Vaccines

8.1.4.1.        Market Revenue and Forecast (2017-2030)

8.1.5.    Recombinant Vaccines

8.1.5.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Swine Vaccines Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Type (2017-2030)

9.1.2.    Market Revenue and Forecast, by Product (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by Product (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by Product (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Type (2017-2030)

9.2.2.    Market Revenue and Forecast, by Product (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by Product (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by Product (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by Product (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Type (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by Product (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Type (2017-2030)

9.3.2.    Market Revenue and Forecast, by Product (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by Product (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by Product (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by Product (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Type (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by Product (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Type (2017-2030)

9.4.2.    Market Revenue and Forecast, by Product (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by Product (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by Product (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by Product (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Type (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by Product (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Type (2017-2030)

9.5.2.    Market Revenue and Forecast, by Product (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Type (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by Product (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Type (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by Product (2017-2030)

Chapter 10.  Company Profiles

10.1.              Merck Animal Health

10.1.1.  Company Overview

10.1.2.  Type Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Ceva

10.2.1.  Company Overview

10.2.2.  Type Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Zoetis

10.3.1.  Company Overview

10.3.2.  Type Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Boehringer Ingelheim GmbH

10.4.1.  Company Overview

10.4.2.  Type Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Elanco

10.5.1.  Company Overview

10.5.2.  Type Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Indian Immunologicals Ltd.

10.6.1.  Company Overview

10.6.2.  Type Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              BiogénesisBagó

10.7.1.  Company Overview

10.7.2.  Type Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Phibro Animal Health

10.8.1.  Company Overview

10.8.2.  Type Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              KM Biologics

10.9.1.  Company Overview

10.9.2.  Type Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           HIPRA

10.10.1.               Company Overview

10.10.2.               Type Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

12.2.              Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39081

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →